Very early researchEnrolling By InvitationNCT07503028
What this trial is testing
An Exploratory Clinical Study Evaluating Allogeneic iPSC-derived Pancreatic Islet Cells (CRG-002) for the Treatment of Diabetic Patients With Hypoglycemia Unawareness or Severe Hypoglycemic Events
Who this might be right for
T1DM - Type 1 Diabetes MellitusPancreatogenic Diabetes Mellitus
Celregen Therapeutics 10